Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12502 | 838 | 31.7 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
40 | 31853 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HIV 2 | Author keyword | 96 | 42% | 21% | 178 |
2 | HIV 2 INFECTION | Author keyword | 21 | 85% | 1% | 11 |
3 | GUINEA BISSAU | Author keyword | 6 | 18% | 4% | 30 |
4 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 | Author keyword | 6 | 50% | 1% | 8 |
5 | HOSP UNIV FANN | Address | 5 | 60% | 1% | 6 |
6 | CLIN UNIV MED 2 | Address | 4 | 50% | 1% | 6 |
7 | CLIN MALAD INFECT IBRAHIMA DIOP MAR | Address | 4 | 44% | 1% | 7 |
8 | HIV 2ROD | Author keyword | 3 | 100% | 0% | 3 |
9 | SERV MED TRANSFUS | Address | 3 | 30% | 1% | 7 |
10 | PROJ SAUDE BANDIM | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 2 | 96 | 42% | 21% | 178 | Search HIV+2 | Search HIV+2 |
2 | HIV 2 INFECTION | 21 | 85% | 1% | 11 | Search HIV+2+INFECTION | Search HIV+2+INFECTION |
3 | GUINEA BISSAU | 6 | 18% | 4% | 30 | Search GUINEA+BISSAU | Search GUINEA+BISSAU |
4 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 | 6 | 50% | 1% | 8 | Search HUMAN+IMMUNODEFICIENCY+VIRUS+TYPE+2 | Search HUMAN+IMMUNODEFICIENCY+VIRUS+TYPE+2 |
5 | HIV 2ROD | 3 | 100% | 0% | 3 | Search HIV+2ROD | Search HIV+2ROD |
6 | HIV DUAL INFECTION | 2 | 50% | 0% | 3 | Search HIV+DUAL+INFECTION | Search HIV+DUAL+INFECTION |
7 | DUAL REACTIVITY | 2 | 43% | 0% | 3 | Search DUAL+REACTIVITY | Search DUAL+REACTIVITY |
8 | HIV2 | 1 | 38% | 0% | 3 | Search HIV2 | Search HIV2 |
9 | DUAL SEROREACTIVITY | 1 | 100% | 0% | 2 | Search DUAL+SEROREACTIVITY | Search DUAL+SEROREACTIVITY |
10 | HIV 2 NATURAL HISTORY | 1 | 100% | 0% | 2 | Search HIV+2+NATURAL+HISTORY | Search HIV+2+NATURAL+HISTORY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNODEFICIENCY VIRUS TYPE 2 | 146 | 67% | 16% | 130 |
2 | HIV 2 INFECTED PATIENTS | 84 | 83% | 6% | 48 |
3 | HIV 2 INFECTION | 46 | 70% | 5% | 38 |
4 | HIV 2 ASSOCIATED MORTALITY | 21 | 90% | 1% | 9 |
5 | GUINEA BISSAU | 18 | 18% | 11% | 89 |
6 | TYPE 2 HIV 2 | 13 | 61% | 2% | 14 |
7 | GAMBIAN PATIENTS | 12 | 75% | 1% | 9 |
8 | PLASMA VIRAL LOAD | 12 | 19% | 6% | 54 |
9 | HIV 2 INFECTED INDIVIDUALS | 11 | 67% | 1% | 10 |
10 | VITRO PHENOTYPIC SUSCEPTIBILITY | 11 | 67% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection | 2014 | 12 | 186 | 45% |
Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis | 2013 | 11 | 94 | 67% |
HIV-2: the forgotten AIDS virus | 2008 | 63 | 95 | 66% |
Towards a better understanding of the epidemiology of HIV-2 | 1999 | 62 | 128 | 74% |
Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2 | 2009 | 34 | 79 | 48% |
Lessons from the second AIDS virus, HIV-2 | 1996 | 69 | 152 | 41% |
Human immunodeficiency virus type-2-A milder, kinder virus: An update | 2012 | 2 | 62 | 74% |
Protective immunity against HIV infection: lessons from HIV-2 infection | 2006 | 5 | 59 | 86% |
Human immunodeficiency virus type 2 | 2002 | 111 | 157 | 29% |
HIV-2 and T cell recognition | 1998 | 21 | 53 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HOSP UNIV FANN | 5 | 60% | 0.7% | 6 |
2 | CLIN UNIV MED 2 | 4 | 50% | 0.7% | 6 |
3 | CLIN MALAD INFECT IBRAHIMA DIOP MAR | 4 | 44% | 0.8% | 7 |
4 | SERV MED TRANSFUS | 3 | 30% | 0.8% | 7 |
5 | PROJ SAUDE BANDIM | 2 | 67% | 0.2% | 2 |
6 | UNIDADE IMUNOL CLIN | 2 | 21% | 1.1% | 9 |
7 | HARVARD AIDS | 2 | 17% | 1.1% | 9 |
8 | UNIDADE RETROVIRUS INFECCOES ASSOCIADAS | 2 | 21% | 0.8% | 7 |
9 | CMG EC | 1 | 100% | 0.2% | 2 |
10 | EA7327 | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000150366 | ACUTE HIV INFECTION//ACUTE RETROVIRAL SYNDROME//BED CEIA |
2 | 0.0000147349 | SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS |
3 | 0.0000113399 | AIDS RESEARCH//IMMUNE COMPLEX DISSOCIATION//ANNALES DE L INSTITUT PASTEUR-VIROLOGY |
4 | 0.0000111673 | HIV 1 GP41//GP120 CD4 INTERACTION//CD4 RECEPTOR |
5 | 0.0000108403 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1 SUBTYPES//CIRCULATING RECOMBINANT FORMS |
6 | 0.0000094350 | HIV 1 PREVALENCE//HIV PREVALENCE//ETHIONETHERLANDS AIDS PROJECT |
7 | 0.0000076318 | UNITE RETROVIROL MOL//ENTROPY EVOLUTION RATE//HIV 1 MOTHER TO CHILD TRANSMISSION |
8 | 0.0000059922 | HGP 30//VACCINE DEV BRANCH//HIV 1 IMMUNOGEN |
9 | 0.0000046655 | IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER |
10 | 0.0000045150 | UNIT CHILD YOUTH//ANNUAL RISK OF TB INFECTION ARTI//CULTURALLY RELEVANT INTERVENTION |